Literature DB >> 29279315

Two Pools of Epoxyeicosatrienoic Acids in Humans: Alterations in Salt-Sensitive Normotensive Subjects.

Fernando Elijovich1, Ginger L Milne2, Nancy J Brown2, Michal Laniado-Schwartzman2, Cheryl L Laffer2.   

Abstract

We measured epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DHETs) in 21 normotensive subjects classified as salt resistant (13) or salt sensitive (8) with an inpatient protocol of salt loading (460 mEq Na+/24 hours, HiNa) and depletion (10 mEq Na+/24 hours+furosemide 40 mg×3, LoNa). No urine EETs were detected; hence, enzyme linked innumosorbent assay 14,15-DHETs (dihydroxyeicosatrienoic acids) were considered the total converted 14,15-urine pool. We report ultra-performance liquid chromatography/tandem mass spectrometry plasma EETs, DHETs, and their sum (plasma total pool) for the 3 regioisomers (8,9-, 11,12-, 14,15-) and their sum (08,15-). In salt-resistant subjects, urine total pool was unchanged by HiNa, decreased by LoNa, and correlated with urine sodium excretion, fractional excretion of Na+, and Na+/K+ ratio for the 3 days of the experiment combined (P<0.03). In contrast, plasma total pool increased in LoNa and did not correlate with natriuresis or Na+/K+ ratio but showed correlations between EETs, blood pressures, and catecholamines and between DHETs and aldosterone (P<0.03). Urine total pool of salt-sensitive was lower than that of salt-resistant subjects in certain phases of the experiment, lacked responses to changes in salt balance, and exhibited limited correlations with natriuresis and Na+/K+ ratio during LoNa only. Plasma total pool of salt-sensitive was lower than in salt-resistant subjects and did not correlate with blood pressures or aldosterone but did with catecholamines. We conclude that the urine total pool reflects a renal pool involved in regulation of natriuresis, whereas the plasma total pools are of systemic origin, uninvolved in Na+ excretion, perhaps contributing to regulation of vascular tone. Data suggest that abnormalities in EETs in salt-sensitive subjects participate in their renal or vascular dysfunction, which has potential therapeutic implications.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  CYP450 eicosanoids; aldosterone; blood pressure; catecholamines; salt sensitive

Mesh:

Substances:

Year:  2017        PMID: 29279315      PMCID: PMC5764817          DOI: 10.1161/HYPERTENSIONAHA.117.10392

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  30 in total

1.  An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.

Authors:  John D Imig; Xueying Zhao; Constantine Z Zaharis; Jeffrey J Olearczyk; David M Pollock; John W Newman; In-Hae Kim; Takaho Watanabe; Bruce D Hammock
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

2.  Hemodynamics and Salt-and-Water Balance Link Sodium Storage and Vascular Dysfunction in Salt-Sensitive Subjects.

Authors:  Cheryl L Laffer; Robert C Scott; Jens M Titze; Friedrich C Luft; Fernando Elijovich
Journal:  Hypertension       Date:  2016-05-09       Impact factor: 10.190

3.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

4.  Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.

Authors:  M H Weinberger; N S Fineberg; S E Fineberg; M Weinberger
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

5.  Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.

Authors:  Ming-Zhi Zhang; Yinqiu Wang; Bing Yao; Leslie Gewin; Shouzuo Wei; Jorge H Capdevila; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-23

6.  Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.

Authors:  Kiyoshi Nakagawa; Vijaykumar R Holla; Yuan Wei; Wen-Hui Wang; Arnaldo Gatica; Shouzou Wei; Shaojun Mei; Crystal M Miller; Dae Ryong Cha; Edward Price; Roy Zent; Ambra Pozzi; Matthew D Breyer; Youfei Guan; John R Falck; Michael R Waterman; Jorge H Capdevila
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

7.  Diagnosis of secondary forms of hypertension. A comprehensive protocol.

Authors:  C E Grim; M H Weinberger; J T Higgins; N J Kramer
Journal:  JAMA       Date:  1977-03-28       Impact factor: 56.272

8.  Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension.

Authors:  Jing Li; Mairead A Carroll; Praveen N Chander; John R Falck; Bhavani Sangras; Charles T Stier
Journal:  Front Biosci       Date:  2008-05-01

Review 9.  Vascular actions of aldosterone.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  J Vasc Res       Date:  2012-11-21       Impact factor: 1.934

10.  The phosphorylation of endogenous Nedd4-2 In Na(+)-absorbing human airway epithelial cells.

Authors:  Noor A S Ismail; Deborah L Baines; Stuart M Wilson
Journal:  Eur J Pharmacol       Date:  2014-03-18       Impact factor: 4.432

View more
  3 in total

Review 1.  Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.

Authors:  John D Imig
Journal:  Pharmacol Ther       Date:  2018-06-30       Impact factor: 12.310

2.  Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids.

Authors:  James M Luther; Dawei S Wei; Kakali Ghoshal; Dungeng Peng; Gail K Adler; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Ambra Pozzi; Nancy J Brown
Journal:  Hypertension       Date:  2021-02-15       Impact factor: 10.190

Review 3.  Immune Mechanisms of Dietary Salt-Induced Hypertension and Kidney Disease: Harry Goldblatt Award for Early Career Investigators 2020.

Authors:  Fernando Elijovich; Thomas R Kleyman; Cheryl L Laffer; Annet Kirabo
Journal:  Hypertension       Date:  2021-07-07       Impact factor: 9.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.